Summary
This filing is an amendment (8-K/A) to a previous 8-K report by IDEXX LABORATORIES, INC. (IDXX) filed on February 21, 2017. The amendment clarifies a scrivener's error within Item 5.02 of the original report, which pertains to director departures. The core information remains that two Class II and Class III Directors, Mr. Thomas Craig and Dr. Barry C. Johnson, respectively, will be retiring from the Board of Directors. Mr. Craig is retiring following the expiration of his term at the 2017 annual meeting of stockholders on May 3, 2017, with his decision not stemming from any disagreements with the company. Dr. Johnson is retiring due to reaching the mandatory retirement age of 73, also effective upon the 2017 annual meeting. The company expresses gratitude for their service. Following these retirements, the Board's size will be reduced to eight members. Specifically, the size of Class II will be reduced to three directors, and the size of Class III will be reduced to two directors, in accordance with company bylaws. This amendment does not introduce new material information beyond the clarification of the prior report.
Key Highlights
- 1Amendment filed to correct a scrivener's error in a prior 8-K filing.
- 2Director Thomas Craig intends to retire from the Board following the 2017 annual meeting of stockholders on May 3, 2017.
- 3Director Barry C. Johnson will retire from the Board upon reaching the mandatory retirement age of 73, also effective at the 2017 annual meeting.
- 4Director retirements are not due to disagreements with the company's operations, policies, or practices.
- 5The Board of Directors' size will be reduced to eight members following the retirements.
- 6The size of Class II and Class III director classes will be adjusted accordingly.